Cargando…

Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper

Innovation leading to significant advances in research and subsequent translation to clinical practice is urgently necessary in early detection of sporadic pancreatic cancer. Addressing this need, the Early Detection of Sporadic Pancreatic Cancer Summit Conference was conducted by Kenner Family Rese...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenner, Barbara J., Chari, Suresh T., Cleeter, Deborah F., Go, Vay Liang W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467583/
https://www.ncbi.nlm.nih.gov/pubmed/25938853
http://dx.doi.org/10.1097/MPA.0000000000000369
_version_ 1782376380006137856
author Kenner, Barbara J.
Chari, Suresh T.
Cleeter, Deborah F.
Go, Vay Liang W.
author_facet Kenner, Barbara J.
Chari, Suresh T.
Cleeter, Deborah F.
Go, Vay Liang W.
author_sort Kenner, Barbara J.
collection PubMed
description Innovation leading to significant advances in research and subsequent translation to clinical practice is urgently necessary in early detection of sporadic pancreatic cancer. Addressing this need, the Early Detection of Sporadic Pancreatic Cancer Summit Conference was conducted by Kenner Family Research Fund in conjunction with the 2014 American Pancreatic Association and Japan Pancreas Society Meeting. International interdisciplinary scientific representatives engaged in strategic facilitated conversations based on distinct areas of inquiry: Case for Early Detection: Definitions, Detection, Survival, and Challenges; Biomarkers for Early Detection; Imaging; and Collaborative Studies. Ideas generated from the summit have led to the development of a Strategic Map for Innovation built upon 3 components: formation of an international collaborative effort, design of an actionable strategic plan, and implementation of operational standards, research priorities, and first-phase initiatives. Through invested and committed efforts of leading researchers and institutions, philanthropic partners, government agencies, and supportive business entities, this endeavor will change the future of the field and consequently the survival rate of those diagnosed with pancreatic cancer.
format Online
Article
Text
id pubmed-4467583
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-44675832015-06-30 Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper Kenner, Barbara J. Chari, Suresh T. Cleeter, Deborah F. Go, Vay Liang W. Pancreas Conference Report Innovation leading to significant advances in research and subsequent translation to clinical practice is urgently necessary in early detection of sporadic pancreatic cancer. Addressing this need, the Early Detection of Sporadic Pancreatic Cancer Summit Conference was conducted by Kenner Family Research Fund in conjunction with the 2014 American Pancreatic Association and Japan Pancreas Society Meeting. International interdisciplinary scientific representatives engaged in strategic facilitated conversations based on distinct areas of inquiry: Case for Early Detection: Definitions, Detection, Survival, and Challenges; Biomarkers for Early Detection; Imaging; and Collaborative Studies. Ideas generated from the summit have led to the development of a Strategic Map for Innovation built upon 3 components: formation of an international collaborative effort, design of an actionable strategic plan, and implementation of operational standards, research priorities, and first-phase initiatives. Through invested and committed efforts of leading researchers and institutions, philanthropic partners, government agencies, and supportive business entities, this endeavor will change the future of the field and consequently the survival rate of those diagnosed with pancreatic cancer. Lippincott Williams & Wilkins 2015-07 2015-06-12 /pmc/articles/PMC4467583/ /pubmed/25938853 http://dx.doi.org/10.1097/MPA.0000000000000369 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Conference Report
Kenner, Barbara J.
Chari, Suresh T.
Cleeter, Deborah F.
Go, Vay Liang W.
Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
title Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
title_full Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
title_fullStr Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
title_full_unstemmed Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
title_short Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
title_sort early detection of sporadic pancreatic cancer: strategic map for innovation—a white paper
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467583/
https://www.ncbi.nlm.nih.gov/pubmed/25938853
http://dx.doi.org/10.1097/MPA.0000000000000369
work_keys_str_mv AT kennerbarbaraj earlydetectionofsporadicpancreaticcancerstrategicmapforinnovationawhitepaper
AT charisuresht earlydetectionofsporadicpancreaticcancerstrategicmapforinnovationawhitepaper
AT cleeterdeborahf earlydetectionofsporadicpancreaticcancerstrategicmapforinnovationawhitepaper
AT govayliangw earlydetectionofsporadicpancreaticcancerstrategicmapforinnovationawhitepaper